EDSA
Edesa Biotech Inc
3.90$
+4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.0% | +0.8% | +13.3% | -14.0% | -2.5% | -43.1% | +5.2% | +0.3% | +66.6% | -40.0% | -366.6% | – | |
| – | +35,553.5% | -99.9% | +99,900.0% | -6.1% | -13.6% | -17.9% | +166.1% | +128.0% | -79.9% | -17.9% | -321.8% | – | |
| – | – | -50.3% | +2,975.8% | -122.0% | – | – | – | -28.0% | -443.8% | – | -184.4% | – | |
| – | -100.0% | – | -8.5% | -100.0% | – | +0.0% | -100.0% | – | +33.3% | -25.0% | +133.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -26.4% | -29.9% | -50.5% | -129.6% | – | +613.1% | -98.5% | +12.7% | +1,273.0% | -99.4% | +17,818.6% | – | |
| – | – | – | – | – | – | +2,243.9% | -112.4% | – | – | -262.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.